Skip to main content
. 2022 Apr 26;13:2242. doi: 10.1038/s41467-022-30026-y

Fig. 7. A model of how CRLKLHL20 determines SERINC5 trafficking and expression.

Fig. 7

CRLKLHL20 catalyzes SERINC5 polyubiquitination at the TGN and produces K33/K48-brached chains at K130 of SERINC5. The K33-linked Ub chain (Ub-K33) potentiates SERINC5 trafficking to the plasma membrane, where it is packaged into HIV-1 virions to inhibit viral infection in the absence of Nef. However, when Nef is expressed, this viral accessory protein recruits CycK/CDK13 to phosphorylate the ICL4 of SERINC5. This phosphorylation triggers SERINC5 conformational change, resulting in recruitment of the AP2 complex to SERINC5 via Nef. SERINC5 is then targeted to the endocytic pathway and degraded in lysosomes via the K48-linked Ub chain (Ub-K48). BioRender was used for making the model.